Last --
Change Today 0.00 / 0.00%
Volume 0.0
6090 On Other Exchanges
Symbol
Exchange
6090 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

human metabolome technologie (6090) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
0.0
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for HUMAN METABOLOME TECHNOLOGIE (6090)

Related News

No related news articles were found.

human metabolome technologie (6090) Related Businessweek News

No Related Businessweek News Found

human metabolome technologie (6090) Details

Human Metabolome Technologies, Inc., a biotechnology company, develops capillary electrophoresis mass spectrometry (CE-MS) based metabolomics technologies and solutions for drug discovery, diagnosis, and food production. It provides metabolome profiling, biomarker discovery, and CE-MS consulting services. The company was founded in 2003 and is headquartered in Tsuruoka, Japan.

Founded in 2003

human metabolome technologie (6090) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

human metabolome technologie (6090) Key Developments

Human Metabolome Technologies, Inc., Annual General Meeting, Jun 28, 2014

Human Metabolome Technologies, Inc., Annual General Meeting, Jun 28, 2014.

Human Metabolome Technologies, Inc. Announces F-SCOPE, a New C13 Metabolite Profiling Platform

Human Metabolome Technologies, Inc. announced F-SCOPE, a new C13 metabolite profiling platform.

Human Metabolome Technologies, Inc. Appoints Alexander Buko as Vice President of HMT America

Human Metabolome Technologies, Inc. announced that Dr. Alexander Buko has joined the executive team in a newly created position as Vice President of HMT America reporting to President Tsutotmu Hoshiba. Dr. Buko brings with him over 30 years of pharmaceutical experience with the FDA, Abbott Labs, and most recently with Biogen Idec where he held the position of Senior Director of Translational Medicine. Alex has successfully led large scale omics projects in neurology, immunology and oncology. With extensive experience in protein and metabolite based profiling, Alex will lead project management and develop HMT's biomarker based platforms.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
6090:JP ¥1,963.00 JPY -51.00

6090 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 6090.
View Industry Companies
 

Industry Analysis

6090

Industry Average

Valuation 6090 Industry Range
Price/Earnings 100.0x
Price/Sales 16.7x
Price/Book 6.6x
Price/Cash Flow 10,496.9x
TEV/Sales 14.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HUMAN METABOLOME TECHNOLOGIE, please visit www.humanmetabolome.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.